We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VFH icon
226
Vanguard Financials ETF
VFH
$13.5B
$294K 0.06%
7,200
– –
RSG icon
227
Republic Services
RSG
$64.8B
$287K 0.06%
8,600
+1,200
+16% +$40.8K
QVCGA
228
DELISTED
QVC Group Inc Series A
QVCGA
$286K 0.06%
297
– –
NGG icon
229
National Grid
NGG
$80.4B
$284K 0.06%
4,980
– –
YHOO
230
DELISTED
Yahoo Inc
YHOO
$284K 0.06%
8,550
+200
+2% +$5.66K
GM icon
231
General Motors
GM
$80.4B
$281K 0.06%
7,826
– –
SCHL icon
232
Scholastic
SCHL
$767M
$281K 0.06%
9,800
– –
DNDN
233
DELISTED
DENDREON CORPORATION
DNDN
$269K 0.06%
91,700
-17,000
-16% -$62.9K
TIF
234
DELISTED
Tiffany & Co.
TIF
$268K 0.06%
3,500
– –
STT icon
235
State Street
STT
$50.6B
$263K 0.05%
4,000
– –
SEE
236
DELISTED
Sealed Air
SEE
$256K 0.05%
9,400
– –
TWC
237
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$247K 0.05%
2,211
-117
-5% -$13.2K
EAT icon
238
Brinker International
EAT
$9.17B
$246K 0.05%
6,066
– –
DON icon
239
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$243K 0.05%
10,500
– –
IEZ icon
240
iShares US Oil Equipment & Services ETF
IEZ
$361M
$241K 0.05%
+3,840
New +$234K
ETR icon
241
Entergy
ETR
$50.2B
$240K 0.05%
7,586
– –
MS icon
242
Morgan Stanley
MS
$331B
$237K 0.05%
8,816
– –
HTH icon
243
Hilltop Holdings
HTH
$2.26B
$231K 0.05%
12,500
+2,500
+25% +$42K
XBI icon
244
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$229K 0.05%
+5,325
New +$216K
PNR icon
245
Pentair
PNR
$10.4B
$226K 0.05%
5,188
-55
-1% -$2.29K
EWA icon
246
iShares MSCI Australia ETF
EWA
$1.39B
$222K 0.05%
+8,800
New +$212K
BTU
247
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$221K 0.05%
856
+54
+7% +$13.8K
BX icon
248
Blackstone
BX
$102B
$220K 0.05%
+9,018
New +$201K
VEU icon
249
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$218K 0.05%
4,500
-300
-6% -$14.1K
EPI icon
250
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$216K 0.04%
14,100
-3,550
-20% -$55K
7 8 9
10
11

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.